Medprin Regenerative Medical Technologies Past Earnings Performance
Past criteria checks 5/6
Medprin Regenerative Medical Technologies has been growing earnings at an average annual rate of 8.8%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 18.8% per year. Medprin Regenerative Medical Technologies's return on equity is 10.3%, and it has net margins of 24.7%.
Key information
8.8%
Earnings growth rate
0.4%
EPS growth rate
Medical Equipment Industry Growth | 16.0% |
Revenue growth rate | 18.8% |
Return on equity | 10.3% |
Net Margin | 24.7% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Medprin Regenerative Medical Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 276 | 68 | 123 | 26 |
30 Jun 24 | 267 | 61 | 125 | 26 |
31 Mar 24 | 244 | 48 | 121 | 26 |
31 Dec 23 | 231 | 41 | 116 | 27 |
30 Sep 23 | 202 | 31 | 104 | 27 |
30 Jun 23 | 186 | 27 | 99 | 29 |
31 Mar 23 | 202 | 37 | 107 | 31 |
01 Jan 23 | 195 | 36 | 106 | 31 |
30 Sep 22 | 190 | 43 | 101 | 33 |
30 Jun 22 | 180 | 45 | 95 | 31 |
31 Mar 22 | 159 | 41 | 80 | 28 |
01 Jan 22 | 154 | 45 | 73 | 26 |
30 Sep 21 | 145 | 46 | 66 | 19 |
30 Jun 21 | 140 | 42 | 62 | 17 |
31 Mar 21 | 137 | 43 | 63 | 17 |
31 Dec 20 | 124 | 37 | 60 | 16 |
31 Dec 19 | 113 | 28 | 65 | 18 |
31 Dec 18 | 86 | -19 | 80 | 21 |
31 Dec 17 | 54 | -19 | 69 | 21 |
Quality Earnings: 301033 has high quality earnings.
Growing Profit Margin: 301033's current net profit margins (24.7%) are higher than last year (15.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 301033's earnings have grown by 8.8% per year over the past 5 years.
Accelerating Growth: 301033's earnings growth over the past year (118.2%) exceeds its 5-year average (8.8% per year).
Earnings vs Industry: 301033 earnings growth over the past year (118.2%) exceeded the Medical Equipment industry -8.8%.
Return on Equity
High ROE: 301033's Return on Equity (10.3%) is considered low.